Characterization of "serosal bridges": routes for antigen and pathogen transport from the female reproductive tract to the intestines.

“浆膜桥”的表征:抗原和病原体从女性生殖道运输到肠道的途径。

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT In this application the researchers propose to 1) characterize “serosal bridges” (SBs), a previously unknown internal route that facilitates antigen and cell transport between the female reproductive tract (FRT) and the gastro-intestinal (GI) tract; and 2) assess the essentiality of SBs and cell migration for transport of Chlamydia spp. from the FRT to the GI tract. The team showed that vaginal immunization with ovalbumin-conjugated 20 nm nanoparticles (NPs) induces serum IgG and primes the intestinal mucosa for secretion of IgA. Surprisingly, it was found that vaginally-instilled soluble antigens and NPs are “delivered” to the lower stomach and duodenum. Moreover, vaginally-instilled Chlamydia spp. elementary bodies (300-450 nm) reach SBs and intestinal serosa within 1-3 hours. In humans and animals Chlamydia spp. spreads from the FRT and persists in the GI tract, where it is resistant to azithromycin treatment. In mice, Chlamydia disseminates internally however, how it transits from the FRT to the GI tract remains unknown. Completion of the proposed work will be critical for understanding dissemination of Chlamydia from the FRT to the GI tract, as well as for developing vaccination strategies to target this pathogen.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vjollca H Konjufca其他文献

Vjollca H Konjufca的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vjollca H Konjufca', 18)}}的其他基金

Unraveling the mechanisms of cell-mediated Chlamydia systemic dissemination.
揭示细胞介导的衣原体系统传播的机制。
  • 批准号:
    10373533
  • 财政年份:
    2021
  • 资助金额:
    $ 22.13万
  • 项目类别:
Unraveling the mechanisms of cell-mediated Chlamydia systemic dissemination.
揭示细胞介导的衣原体系统传播的机制。
  • 批准号:
    10517514
  • 财政年份:
    2021
  • 资助金额:
    $ 22.13万
  • 项目类别:

相似海外基金

Development of novel ABO blood group antigen targeting peptide that suppress rejection during ABO-incompatible kidney transplantation
开发新型 ABO 血型抗原靶向肽,可抑制 ABO 不相容肾移植过程中的排斥反应
  • 批准号:
    23791736
  • 财政年份:
    2011
  • 资助金额:
    $ 22.13万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Antigen Targeting in plasmazytoide dendritische Zellen - Nutzung zur Toleranzinduktion und Vakzinierung
浆细胞样树突状细胞中的抗原靶向 - 用于耐受诱导和疫苗接种
  • 批准号:
    211908646
  • 财政年份:
    2011
  • 资助金额:
    $ 22.13万
  • 项目类别:
    Research Grants
Development of Novel Prostate Specific Membrane Antigen Targeting Probes for Prostate Cancer Imaging
开发用于前列腺癌成像的新型前列腺特异性膜抗原靶向探针
  • 批准号:
    23791413
  • 财政年份:
    2011
  • 资助金额:
    $ 22.13万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Immunregulation bei entzündlichen Darmerkrankungen durch Antigen Targeting des DEC-205 Rezeptors - Mechanismen und Funktion
通过 DEC-205 受体抗原靶向调节炎症性肠病 - 机制和功能
  • 批准号:
    168824599
  • 财政年份:
    2010
  • 资助金额:
    $ 22.13万
  • 项目类别:
    Research Grants
Anti-tumor vaccine by the use of antigen targeting to lectins expressed on dendritic cells
利用抗原靶向树突状细胞上表达的凝集​​素的抗肿瘤疫苗
  • 批准号:
    21790144
  • 财政年份:
    2009
  • 资助金额:
    $ 22.13万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of novel oncofetal antigen targeting immunotherapy for refractory ovarian carcinoma
难治性卵巢癌新型癌胎抗原靶向免疫疗法的开发
  • 批准号:
    21592127
  • 财政年份:
    2009
  • 资助金额:
    $ 22.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vaccine enhancement through antigen targeting
通过抗原靶向增强疫苗
  • 批准号:
    6791150
  • 财政年份:
    2004
  • 资助金额:
    $ 22.13万
  • 项目类别:
Salmonella type III-mediated antigen targeting to induce cellular immunity: characterzition of effector and memory T cell populations after oral vaccination
沙门氏菌 III 型介导的抗原靶向诱导细胞免疫:口服疫苗接种后效应和记忆 T 细胞群的特征
  • 批准号:
    5265936
  • 财政年份:
    2000
  • 资助金额:
    $ 22.13万
  • 项目类别:
    Priority Programmes
TB ANTIGEN TARGETING TO ENHANCE T CELL RESPONSE
靶向结核抗原以增强 T 细胞反应
  • 批准号:
    2882120
  • 财政年份:
    1999
  • 资助金额:
    $ 22.13万
  • 项目类别:
TB ANTIGEN TARGETING TO ENHANCE T CELL RESPONSE
靶向结核抗原以增强 T 细胞反应
  • 批准号:
    2413472
  • 财政年份:
    1998
  • 资助金额:
    $ 22.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了